Schizophrenia Clinical Trial
Official title:
Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series
Verified date | November 2015 |
Source | University of Manchester |
Contact | n/a |
Is FDA regulated | No |
Health authority | United Kingdom: Research Ethics Committee |
Study type | Interventional |
The aim of the case series study is to explore if a self directed version of the Positive Parenting Program (Triple P) is a feasible and acceptable intervention for individuals with psychosis who are parents.
Status | Completed |
Enrollment | 1 |
Est. completion date | November 2014 |
Est. primary completion date | November 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: - 1. Parents/caregivers (mothers or fathers) with a Schizophrenia-spectrum diagnosis who are: 2. Aged 18 years or more 3. Have at least one child aged 3-10 years old 4. Have a least 10 hours contact time per week with the child. 5. Identify difficulties in parenting during assessment Exclusion Criteria: - 1. Parents/caregivers and family members who do not have good working knowledge of English. They should have enough practical experience to be able to adequately use the English language to understand and respond to questions, to read and complete questionnaires 2. Families who do not have at least one adult who has basic literacy skills 3. Families where there is known intention for their children to be taken into care or where the parent(s) have no regular contact with the index child 4. Parents with a clinical schizophrenia-spectrum diagnosis who have recently been discharged from acute in-patient care for their condition and have less than four weeks of stabilisation of psychotic experiences (operationally defined as no significant change to management or severity of symptoms in a four-week period since discharge as assessed from case notes). This is because if a potential parent with schizophrenia had recently required an inpatient stay, it is important to give them sufficient time to readjust to living in the community and ensure sufficient time is provided for symptom stabilisation before taking part 5. Families seeking support from services regarding child management issues 6. Families actively involved in another current cognitive behavioural therapy based intervention |
Intervention Model: Single Group Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
United Kingdom | University of Manchester | Manchester |
Lead Sponsor | Collaborator |
---|---|
University of Manchester | Lancashire Care NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Psychotic Symptom Rating Scales (PSYRATS) | Ax from 0 - 16 weeks. | Initial Ax, Multiple Baseline Ax, Final Baseline Ax, Up to 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks. | No |
Primary | Parenting and Family Adjustment Scale (PAFAS) | Ax from 0 - 16 weeks. | Initial Ax, Multiple Baselines, Final Baseline, Support Sessions, End Ax, Follow Up. Ax from 0 - 16 weeks. | No |
Secondary | Eyberg Child Behaviour Inventory (ECBI) | Ax from 0 - 16 weeks. | Initial Ax, Final Ax, End Ax, Follow Up. Ax from 0 - 16 weeks. | No |
Secondary | Parenting Task Checklist (PTC) | Ax from 0 - 16 weeks. | Initial Ax, Final Ax, End Ax, Follow Up. Ax from 0 - 16 weeks. | No |
Secondary | Depression Anxiety and Stress Scale (DASS-21) | Ax from 0 - 16 weeks. | Initial Ax, Final Ax, End Ax, Follow Up. Ax from 0 - 16 weeks. | No |
Secondary | Work and Social Adjustment Scale (WSAS) | Ax from 0 - 16 weeks. | Initial Ax, Final Ax, End Ax, Follow Up. Ax from 0 - 16 weeks. | No |
Secondary | Warwick-Edinburgh Mental Well-being Scale (WEMWBS) | Ax from 0 - 16 weeks. | Initial Ax, Final Ax, End Ax, Follow Up. Ax from 0 - 16 weeks. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |